GPs have reported the ‘new trend’, saying practices are being targeted by people looking to obtain medicines via telehealth.

The parliamentary report on the health impacts of alcohol and other drugs also backed AOD training at medical colleges.

It saw healthcare teams and community leaders gather to strengthen preventive care for Aboriginal and Torres Strait Islander peoples.

Thousands of women will gain subsidised access to triptorelin from October in the wake of Zoladex’s exit from the Australian market.

It aims to help GPs understand the risks, benefits and necessity of off-label prescribing, while recognising the ‘gravity it deserves’.

If widely adopted, these quality prescribing indicators could lead to reduced medication harm and improved patient outcomes.

It’s designed as a ‘practical roadmap for care’ in everyday general practice to support consistent, evidence-based care and reduce diagnostic timeframes.

The simpler, clinically focused approach aims to help doctors accurately diagnose a heart attack, particularly in women.

With Victoria’s carer allowance the nation’s lowest, the RACGP says carers must be reimbursed for the out-of-pocket cost of medicines.

With 52 Victorian diagnoses reported since 1 August, GPs are urged to test all patients with symptoms consistent with the disease.

Amid warnings that ‘reckless’ prescribing jeopardises clinicians’ right to practise, it’s released practical guidance and case studies for prescribing off-label and unapproved medicines.

While overall STI rates eased slightly last year in Australia, the rate of syphilis in women has jumped by 167% in 10 years.

After one of the largest ever RACGP Fellowship ceremonies, the GPs’ work will ‘strengthen our healthcare system for years to come’.

Tasked to provide advice on NSW prescribing, a GP has walked away after claims of being ignored, with the RACGP calling the move ‘an absolute red flag’.

The Victorian Women’s Pain Standard reassures women they have a right to be ‘taken seriously and believed’ within healthcare.

The recommended upper limit for supplements could be sharply reduced, amid ongoing concern that high doses can cause nerve damage.

Testing found it contained semaglutide at a level eight times higher than found in products in the ARTG, prompting new and urgent warnings.

Amid the rise, a study reaffirms that an anti-Müllerian hormone test must not be viewed as a ‘crystal ball for reproductive future’.

It examines what must change to make work fulfilling, warning of consult lengths, unequal caring loads, and an expectation to ‘excel simultaneously in multiple roles’.

‘Being left behind in these areas could have significant financial implications for GPs,’ writes Dr Rob Hosking.